Abstract
Cardiovascular diseases (CVD), followed by cancers, are the leading causes of death worldwide; recognized for being complex diseases with a multifactorial cause, and that they have a common interaction and risk factors. In recent decades, cardio-oncology has focused on the prevention and treatment of CVD in cancer survivors as a result of the cardiotoxicity of antineoplastic agents. On th…